Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GUFICBIO.NSthis companyGufic Biosciences Limited	₹474.35	42.78×	4.13×	2.91×	19.97×	-117.2%	36.0%	12.8%	6.8%	9.7%	8.1%	-0.7%	0.61×	2.13×	3.29×	1.55×	0.0%	6	—	1	C-
AKUMS.NSAkums Drugs & Pharmaceuticals Ltd.	₹765.85	27.96×	2.15×	1.64×	10.95×	-35.7%	21.5%	8.4%	5.9%	7.7%	5.6%	13.7%	0.05×	-0.36×	3.91×	3.25×	0.0%	—	—	2	C
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
MOREPENLAB.NSMorepen Laboratories Limited	₹99.15	21.5×	1.64×	1.13×	12.61×	-82.7%	37.8%	4.9%	5.3%	7.6%	4.7%	-7.1%	0.17×	0.8×	5.43×	2.37×	0.5%	5	5.38	3	B
NATCOPHARM.NSNATCO Pharma Limited	₹804.35	12.65×	1.95×	4.4×	9.86×	351.2%	83.1%	30.2%	34.8%	15.4%	11.3%	7.7%	0.08×	-0.48×	33.51×	3.01×	0.5%	4	—	3	B+
Peer median	—	21.5×	2.15×	2.81×	12.61×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	2.2%	0.08×	0.07×	7.77×	3.01×	0.5%	5	5.38	3	—